Vera Therapeutics Stock Price History
| VERA Stock | USD 27.10 0.09 0.33% |
Below is the normalized historical share price chart for Vera Therapeutics extending back to August 28, 1985. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Vera Therapeutics stands at 27.10, as last reported on the 26th of February, with the highest price reaching 27.95 and the lowest price hitting 26.08 during the day.
If you're considering investing in Vera Stock, it is important to understand the factors that can impact its price. Vera Therapeutics owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.25, which indicates the firm had a -0.25 % return per unit of risk over the last 3 months. Vera Therapeutics exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Vera Therapeutics' Risk Adjusted Performance of (0.13), variance of 13.56, and Coefficient Of Variation of (535.95) to confirm the risk estimate we provide.
At present, Vera Therapeutics' Total Stockholder Equity is projected to increase significantly based on the last few years of reporting. The current year's Common Stock Shares Outstanding is expected to grow to about 51.6 M, whereas Common Stock Total Equity is forecasted to decline to about 26.9 K. . The current year's Price Earnings To Growth Ratio is expected to grow to 0.20, whereas Price To Sales Ratio is forecasted to decline to 282.21. Vera Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 14th of May 2021 | 200 Day MA 39.6151 | 50 Day MA 37.6492 | Beta 1.109 |
Vera |
Sharpe Ratio = -0.2544
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | VERA |
Estimated Market Risk
| 3.79 actual daily | 33 67% of assets are more volatile |
Expected Return
| -0.97 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.25 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Vera Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Vera Therapeutics by adding Vera Therapeutics to a well-diversified portfolio.
Vera Therapeutics Stock Price History Chart
There are several ways to analyze Vera Stock price data. The simplest method is using a basic Vera candlestick price chart, which shows Vera Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | November 29, 2024 | 49.75 |
| Lowest Price | February 25, 2025 | 27.1 |
Vera Therapeutics February 26, 2025 Stock Price Synopsis
Various analyses of Vera Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Vera Stock. It can be used to describe the percentage change in the price of Vera Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Vera Stock.| Vera Therapeutics Price Rate Of Daily Change | 1.00 | |
| Vera Therapeutics Price Daily Balance Of Power | (0.05) | |
| Vera Therapeutics Accumulation Distribution | 53,205 | |
| Vera Therapeutics Price Action Indicator | 0.04 |
Vera Therapeutics February 26, 2025 Stock Price Analysis
Vera Stock Price History Data
The price series of Vera Therapeutics for the period between Thu, Nov 28, 2024 and Wed, Feb 26, 2025 has a statistical range of 22.65 with a coefficient of variation of 16.2. The daily prices for the period are distributed with arithmetic mean of 39.81. The median price for the last 90 days is 41.92.| Open | High | Low | Close | Volume | ||
| 02/25/2025 | 26.82 | 27.95 | 26.08 | 27.10 | 795,229 | |
| 02/24/2025 | 28.71 | 29.25 | 27.13 | 27.19 | 821,960 | |
| 02/21/2025 | 29.80 | 30.88 | 28.34 | 28.58 | 1,214,844 | |
| 02/20/2025 | 29.36 | 30.06 | 29.31 | 29.61 | 681,730 | |
| 02/19/2025 | 29.11 | 29.87 | 28.70 | 29.52 | 1,164,664 | |
| 02/18/2025 | 27.84 | 29.35 | 26.86 | 29.18 | 2,316,844 | |
| 02/14/2025 | 34.25 | 34.50 | 25.99 | 27.46 | 6,404,347 | |
| 02/13/2025 | 34.59 | 34.79 | 33.45 | 34.18 | 566,848 | |
| 02/12/2025 | 33.22 | 34.60 | 32.63 | 34.55 | 443,922 | |
| 02/11/2025 | 35.52 | 35.52 | 33.60 | 34.04 | 496,895 | |
| 02/10/2025 | 36.20 | 36.48 | 34.99 | 35.88 | 539,461 | |
| 02/07/2025 | 37.19 | 37.42 | 36.09 | 36.14 | 451,051 | |
| 02/06/2025 | 38.22 | 38.91 | 36.72 | 37.18 | 833,511 | |
| 02/05/2025 | 38.05 | 38.30 | 37.03 | 38.11 | 479,250 | |
| 02/04/2025 | 37.08 | 38.14 | 36.19 | 38.07 | 424,908 | |
| 02/03/2025 | 36.33 | 37.20 | 36.03 | 36.54 | 461,695 | |
| 01/31/2025 | 37.44 | 38.05 | 36.81 | 37.28 | 482,944 | |
| 01/30/2025 | 38.48 | 40.47 | 37.19 | 37.48 | 841,164 | |
| 01/29/2025 | 36.48 | 39.10 | 35.62 | 37.93 | 979,650 | |
| 01/28/2025 | 36.88 | 37.51 | 34.88 | 35.98 | 874,940 | |
| 01/27/2025 | 33.51 | 35.13 | 33.18 | 34.84 | 653,111 | |
| 01/24/2025 | 34.19 | 35.00 | 33.21 | 33.92 | 547,064 | |
| 01/23/2025 | 33.42 | 34.33 | 33.06 | 34.09 | 1,004,760 | |
| 01/22/2025 | 33.52 | 34.10 | 33.10 | 33.77 | 606,837 | |
| 01/21/2025 | 34.00 | 34.35 | 33.34 | 33.70 | 1,015,879 | |
| 01/17/2025 | 33.03 | 34.33 | 32.25 | 33.37 | 1,045,382 | |
| 01/16/2025 | 33.84 | 34.54 | 32.39 | 32.78 | 719,378 | |
| 01/15/2025 | 35.37 | 36.28 | 33.28 | 33.88 | 977,404 | |
| 01/14/2025 | 35.00 | 35.00 | 33.28 | 34.59 | 695,737 | |
| 01/13/2025 | 35.00 | 35.46 | 31.77 | 34.77 | 1,422,522 | |
| 01/10/2025 | 41.14 | 41.93 | 36.79 | 37.02 | 944,205 | |
| 01/08/2025 | 41.89 | 42.23 | 40.80 | 42.19 | 403,110 | |
| 01/07/2025 | 42.13 | 42.90 | 41.51 | 42.10 | 572,078 | |
| 01/06/2025 | 43.02 | 43.76 | 41.57 | 42.26 | 588,946 | |
| 01/03/2025 | 42.72 | 43.69 | 42.63 | 43.22 | 297,848 | |
| 01/02/2025 | 42.42 | 42.99 | 41.87 | 42.20 | 382,459 | |
| 12/31/2024 | 42.26 | 43.29 | 41.67 | 42.29 | 449,910 | |
| 12/30/2024 | 41.18 | 42.29 | 40.49 | 42.06 | 527,523 | |
| 12/27/2024 | 42.26 | 43.06 | 40.91 | 41.41 | 1,801,066 | |
| 12/26/2024 | 42.13 | 43.12 | 41.20 | 42.45 | 296,418 | |
| 12/24/2024 | 42.43 | 42.44 | 41.33 | 41.92 | 158,565 | |
| 12/23/2024 | 42.11 | 42.87 | 41.53 | 42.31 | 359,240 | |
| 12/20/2024 | 41.66 | 45.06 | 40.96 | 42.60 | 2,228,091 | |
| 12/19/2024 | 41.50 | 42.58 | 40.74 | 42.05 | 557,607 | |
| 12/18/2024 | 43.81 | 44.40 | 40.74 | 41.36 | 565,769 | |
| 12/17/2024 | 43.53 | 44.69 | 43.02 | 43.91 | 546,043 | |
| 12/16/2024 | 44.04 | 45.27 | 43.62 | 43.96 | 357,015 | |
| 12/13/2024 | 45.26 | 46.29 | 43.13 | 44.05 | 569,203 | |
| 12/12/2024 | 46.50 | 47.04 | 44.54 | 45.11 | 452,725 | |
| 12/11/2024 | 47.61 | 47.74 | 46.42 | 46.46 | 390,647 | |
| 12/10/2024 | 47.75 | 48.49 | 46.76 | 46.92 | 378,843 | |
| 12/09/2024 | 49.15 | 49.58 | 47.08 | 47.51 | 354,664 | |
| 12/06/2024 | 48.57 | 49.77 | 48.21 | 48.46 | 324,221 | |
| 12/05/2024 | 48.86 | 49.60 | 47.81 | 48.11 | 383,066 | |
| 12/04/2024 | 49.96 | 50.37 | 48.74 | 49.46 | 314,538 | |
| 12/03/2024 | 48.84 | 50.62 | 48.59 | 49.38 | 345,445 | |
| 12/02/2024 | 49.96 | 51.27 | 49.23 | 49.55 | 672,502 | |
| 11/29/2024 | 49.06 | 50.12 | 48.37 | 49.75 | 339,039 | |
| 11/27/2024 | 47.49 | 49.36 | 47.07 | 48.83 | 436,819 | |
| 11/26/2024 | 46.47 | 47.84 | 45.99 | 47.46 | 449,890 | |
| 11/25/2024 | 48.76 | 49.47 | 46.55 | 47.27 | 519,078 |
About Vera Therapeutics Stock history
Vera Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Vera is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Vera Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Vera Therapeutics stock prices may prove useful in developing a viable investing in Vera Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 49.1 M | 51.6 M | |
| Net Income Applicable To Common Shares | 102.4 M | 107.5 M |
Vera Therapeutics Quarterly Net Working Capital |
|
Vera Therapeutics Stock Technical Analysis
Vera Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Analyst Advice Now
Analyst AdviceAnalyst recommendations and target price estimates broken down by several categories |
| All Next | Launch Module |
Vera Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Vera Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Vera Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Vera to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.13) | |||
| Jensen Alpha | (0.70) | |||
| Total Risk Alpha | (0.72) | |||
| Treynor Ratio | (0.54) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Vera Stock analysis
When running Vera Therapeutics' price analysis, check to measure Vera Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vera Therapeutics is operating at the current time. Most of Vera Therapeutics' value examination focuses on studying past and present price action to predict the probability of Vera Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vera Therapeutics' price. Additionally, you may evaluate how the addition of Vera Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |